ALT icon

Altimmune

169 hedge funds and large institutions have $243M invested in Altimmune in 2024 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 60 increasing their positions, 46 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10:

less funds holding

Funds holding:

4.2% less ownership

Funds ownership: 59.84%55.64% (-4.2%)

14% less capital invested

Capital invested by funds: $282M → $243M (-$39.2M)

19% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 26

Holders
169
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$11.8M
Puts
$8.53M
Net Calls
Net Calls Change

Top Buyers

1 +$4.42M
2 +$2.89M
3 +$1.79M
4
Jane Street
Jane Street
New York
+$1.67M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$1.22M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$212K
77
$211K
78
$207K
79
$202K
80
$197K
81
$195K
82
$190K
83
$183K
84
$169K
85
$166K
86
$162K
87
$151K
88
$148K
89
$147K
90
$145K
91
$144K
92
$144K
93
$143K
94
$141K
95
$135K
96
$132K
97
$125K
98
$124K
99
$123K
100
$123K